Regulation vital for access to medicines

The authors say medical product regulatory systems are central to health systems and are part of the World Health Organization’s (WHO) six core building blocks of health systems but are rarely featured prominently in global health programs.

A lack of regulation can lead to fatalities, the authors wrote, citing examples such as tainted cough syrup which entered Panama in 2006 leading to more than 100 deaths.

“As the challenges of globalisation mount, and efforts to provide medical products to low- and middle-income countries